MetaCap

Cellectar Biosciences Statistics

NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.797-0.1036 (-11.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cellectar Biosciences by the numbers

Cellectar Biosciences has a market capitalization of $8.0 million based on 10.04M shares outstanding. With trailing EPS of $-2.34, Cellectar Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.2% below its 50-day average and 67.6% below its 200-day average.

Average daily trading volume is 97.96K shares, or about $78,073 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLRB valuation vs. peer median

CLRB compared with the median of 8 peer companies
MetricCLRBPeer medianDifference
Market cap$8.00M$8.19M-2%
Avg. volume97.96K89.01K+10%

Peer median across 8 companies: DARE, PTN, PHIO, MBRX, QNTM, HIND, VTGN, LEXX.

Valuation

Price and trading

Previous close
0.9006
Open
0.90
Day range
0.7596 – 0.90
52-week range
0.7596 – 4.70
52-week change
-72.13%
Beta
—
Volume
80.36K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
8.00M
Forward Pe
-0.39
Eps
-2.34
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.70
Week52 Low
0.76
Avg Volume
97,959.00
Shares Outstanding
10.04M
Ma50
1.48
Ma200
2.46
Earnings Date
Nov 10, 2026
Pct From52w High
-83.04%
Pct From52w Low
4.92%

Related